Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients

British Journal of Dermatology

Volumn 147, Issue 3, 2002, Pages 528-537

  Hanifin, J ^a,d   Gupta, A K ^b   Rajagopalan, R ^c   Parker, Christine ^e  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c GLAXOSMITHKLINE   (United States)

^d University of North Carolina   (United States)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Adrenal suppression; Atopic dermatitis; Atrophy; Corticosteroids; Intermittent dosing

Indexed keywords

EMOLLIENT AGENT; FLUTICASONE PROPIONATE;

ACNE; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; ERYTHEMA; FEMALE; HUMAN; INFANT; MAINTENANCE THERAPY; MALE; MULTICENTER STUDY; PAPULAR SKIN DISEASE; PATIENT MONITORING; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SCORING SYSTEM; SKIN ATROPHY; SKIN EDEMA; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EMOLLIENTS; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INFANT; MALE; MIDDLE AGED; OINTMENTS; RECURRENCE; TREATMENT OUTCOME;

EID: 0036046661     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.05006.x     Document Type: Article

References (33)

1. Diagnostic features of atopic dermatitis
2. The relation of stress and family environment to atopic dermatitis symptoms in children
3. The family impact of childhood atopic dermatitis: The dermatitis family impact questionnaire
4. Atopic eczema: Its impact on the family and financial cost
5. The occurrence of atopic dermatitis in North Europe: An international questionnaire study
6. Prevalence of childhood and adolescent atopic dermatitis in a Japanese population: Comparison with the disease frequency examined 20 years ago
7. The prevalence of atopic dermatitis in Oregon schoolchildren
8. The prevalence of childhood atopic eczema in the general population
9. Practical management of atopic eczema
10. Do topical steroids reduce relapses in adults with atopic dermatitis?
11. Systematic review of treatments of atopic eczema
12. Old, new and emerging therapies for atopic dermatitis
13. Managing pediatric atopic dermatitis
14. Fluticasone propionate 0.05% cream once daily versus clobetasone butyrate 0.05% cream twice daily in children with atopic dermatitis
15. Effect of percutaneous absorption of hydrocortisone on adrenocortical responsiveness in infants with severe skin disease
16. Update on therapy of atopic dermatitis
17. Management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate
18. The human pharmacology of fluticasone propionate
19. Topical fluticasone propionate. A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders
20. Assessment of HPA-axis suppression with fluticasone cream 0.05% in patients with extensive psoriasis or eczema
21. Left-right comparison study of the combination of fluticasone propionate and UV-A vs either fluticasone propionate or UV-A alone for the long-term treatment of vitiligo
22. Grading of the severity of atopic dermatitis
23. A comparison of twice daily and once-daily administration of fluticasone propionate cream, 0.05%, in the treatment of eczema
24. Nonparametric estimation from incomplete observations
25. Topical corticosteroid phobia in patients with atopic eczema
26. Long-term intermittent treatment of chronic hand eczema with mometasone furoate
27. An open study of efficacy and safety of long-term treatment with mometasone furoate fatty cream in the treatment of adult patients with atopic dermatitis
28. Intermittent maintenance therapy in chronic hand eczema with clobetasol propionate and flupredniden acetate
29. The kinetics of skin thinning induced by topical fluticasone propionate 0.05% cream in volunteer subjects
30. The safety of fluticasone propionate cream 0.05% for the treatment of severe and extensive atopic dermatitis in children as young as 3 months
31. Intermittent dosing with topical fluticasone propionate delays the time to relapse in adults and children with chronic atopic dermatitis, two randomised controlled studies
32. Atopic dermatitis in children: Who cares? Who pays?